INS and type 2 diabetes mellitus: The focus of this paper is to evaluate treatment persistence and hypoglycaemia in adult patients with T2D on prior basal insulin therapy who were switched to Gla‐300 versus other first‐ or second‐generation basal insulins in a real‐world clinical setting in the USA.